Press release
Vaccine Delivery Devices Market is expected to double, reaching USD 11.8 billion by 2034
Vaccine Delivery Devices Market
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73477
The market includes syringes, auto-disable syringes, needle-free injectors, microneedles, jet injectors, and novel oral/intranasal delivery systems. Increasing government vaccination drives, rising investment in pandemic preparedness, and patient-centric innovations are propelling growth.
Market Overview
• Market Size (2024): USD 5.9 billion
• Forecast (2034): USD 11.8 billion
• CAGR (2025-2034): 7.2%
Key Highlights:
• Expansion of global immunization programs for children and adults.
• Growing adoption of needle-free and microneedle technologies for pain-free delivery.
• Widespread use of auto-disable syringes in WHO-backed vaccine campaigns.
• Strong government and private sector investment in pandemic response capacity.
Segmentation Analysis
By Product Type:
• Syringes
o Standard Syringes
o Auto-Disable Syringes
• Needle-Free Injectors
• Microneedle Patches
• Jet Injectors
• Others (oral, intranasal delivery systems)
By Technology:
• Conventional Delivery Devices
• Needle-Free & Smart Delivery Systems
By Vaccine Type:
• Pediatric Vaccines (measles, polio, diphtheria, etc.)
• Influenza Vaccines
• COVID-19 & Pandemic Vaccines
• HPV Vaccines
• Others (malaria, RSV, cancer vaccines under development)
By End Use:
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Research & Academic Institutes
• Immunization Programs (NGOs, WHO, UNICEF)
Segmentation Summary:
Syringes dominate today's market, particularly auto-disable syringes for mass immunization campaigns. However, needle-free and microneedle devices are growing fastest due to patient convenience and reduced safety risks.
Explore Full Report here: https://exactitudeconsultancy.com/reports/73477/vaccine-delivery-devices-market
Regional Analysis
North America
• Largest share (~38% in 2024).
• Strong adoption of advanced vaccine delivery technologies.
• High vaccination coverage and government-backed immunization initiatives.
Europe
• ~30% share.
• Germany, UK, and France lead in adoption of microneedles and needle-free systems.
• EMA approvals driving faster integration of novel vaccine delivery solutions.
Asia-Pacific
• Fastest-growing region with CAGR ~8.5%.
• India and China drive high demand via large-scale vaccination campaigns.
• Growing investments in biotech and local vaccine manufacturing capacity.
Latin America
• Brazil and Mexico leading in immunization coverage and device adoption.
• Increasing government procurement of auto-disable syringes.
Middle East & Africa
• Expanded WHO and UNICEF-led vaccination programs.
• GCC countries adopting advanced vaccine delivery devices for seasonal and pandemic readiness.
Regional Summary:
North America and Europe lead in advanced technology adoption, while Asia-Pacific dominates in growth potential due to its vast immunization base and local manufacturing ecosystems.
Market Dynamics
Key Growth Drivers:
• Rising demand for childhood and adult vaccination programs.
• Increased pandemic preparedness and vaccination infrastructure.
• Strong push for needle-free, pain-free, and safer devices.
• Growing investments in DNA, mRNA, and next-gen vaccines.
Key Challenges:
• High costs of advanced vaccine delivery systems.
• Cold chain and logistical challenges in emerging markets.
• Regulatory hurdles for novel delivery devices.
• Vaccine hesitancy in some regions.
Latest Trends:
• Microneedle patches gaining momentum for painless, self-administered vaccines.
• Needle-free injectors expanding in mass immunization campaigns.
• Integration of smart syringes with tracking features for dose monitoring.
• Increasing partnerships between vaccine manufacturers and device makers.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73477
Competitor Analysis
Major Players in the Market:
• Becton, Dickinson and Company (BD) - leading syringe and auto-disable systems.
• Gerresheimer AG - drug delivery device manufacturing.
• PharmaJet, Inc. - needle-free injectors.
• Vaxxas Pty Ltd - microneedle vaccine patch developer.
• 3M Company - microneedle technology.
• West Pharmaceutical Services, Inc.
• Schott AG (glass syringes and packaging).
• Terumo Corporation.
• Cardinal Health, Inc.
• Microdermics Inc. (microneedle innovations).
Competitive Summary:
BD dominates with auto-disable syringes, while PharmaJet and Vaxxas pioneer needle-free and microneedle solutions. 3M and West focus on advanced drug-device technologies. Competition centers on safety, patient comfort, scalability, and cost-effectiveness.
Conclusion
The Vaccine Delivery Devices Market, valued at USD 5.9 billion in 2024, is projected to reach USD 11.8 billion by 2034, expanding at a CAGR of 7.2%.
Key Takeaways:
• Syringes dominate, but needle-free and microneedle devices are the future.
• North America and Europe lead adoption, while Asia-Pacific grows fastest due to large-scale immunization needs.
• Pandemic preparedness and new vaccine platforms will boost innovation.
• Future devices will be painless, connected, and patient-friendly, ensuring wider immunization coverage.
The next decade will mark a transformation in vaccination from traditional syringe-based delivery to intelligent, needle-free, and self-administrable systems, bridging gaps in global immunization access.
This report is also available in the following languages : Japanese (ワクチン送達デバイス市場), Korean (백신 투여 장치 시장), Chinese (疫苗输送装置市场), French (Marché des dispositifs d'administration de vaccins), German (Markt für Impfstoffverabreichungsgeräte), and Italian (Mercato dei dispositivi per la somministrazione di vaccini), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/73477/vaccine-delivery-devices-market#request-a-sample
Our More Reports:
Ocular Drug Delivery Systems Market
https://exactitudeconsultancy.com/reports/73487/ocular-drug-delivery-systems-market
Glycated Haemoglobin Testing Market
https://exactitudeconsultancy.com/reports/73489/glycated-haemoglobin-testing-market
PFAS Testing Market
https://exactitudeconsultancy.com/reports/73491/pfas-testing-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vaccine Delivery Devices Market is expected to double, reaching USD 11.8 billion by 2034 here
News-ID: 4182426 • Views: …
More Releases from Exactitude Consultancy
Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at …
Introduction
Cell therapy has emerged as a transformative pillar of modern medicine, offering the potential to repair, replace, or regenerate damaged tissues and organs. From CAR-T cell therapies for oncology to stem cell therapies for regenerative medicine, the field is redefining treatment paradigms across oncology, neurology, cardiology, and rare diseases.
As clinical pipelines expand and more therapies achieve regulatory approval, demand for efficient and scalable cell therapy manufacturing has surged. Specialized technologies…
Despite safety concerns, adavosertib exhibits early antitumor activity in uterin …
Uterine serous carcinoma (USC) is a rare but highly aggressive subtype of endometrial cancer, accounting for less than 10% of endometrial cancer cases but contributing to a disproportionately high mortality rate. It is often diagnosed at advanced stages, making it difficult to treat with conventional methods.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72873
In recent years, the treatment landscape has expanded beyond chemotherapy and surgery to include targeted therapies,…
Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Imp …
Catheter-related bloodstream infections (CRBSIs) are among the most common and serious complications associated with intravascular catheters used in hospitals and long-term care settings. These infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. With the rising use of central venous catheters, particularly among critically ill patients, oncology cases, and those requiring long-term intravenous therapy, the global demand for effective prevention and treatment solutions is growing…
ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
Introduction
Antibody-drug conjugates (ADCs) represent one of the most innovative breakthroughs in oncology, combining the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. By delivering highly toxic payloads directly to cancer cells, ADCs minimize systemic toxicity and enhance therapeutic efficacy.
As cancer incidence rises worldwide and the limitations of conventional chemotherapy become more evident, ADC technology is gaining momentum. With advancements in linker chemistry, payload design, and next-generation…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
